Pharmacologic aids to smoking cessation
Abstract
Nicotine replacement and bupropion have shown significant benefits for those seeking pharmacologic assistance with smoking cessation. This discussion reviews the efficacy literature for both treatments, including potential side effects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NRT roughly doubles quit rates compared to placebo.
“NRT roughly doubles quit rates compared to placebo”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [210]
A large percentage of subjects relapses to smoking within 6 to 12 months after NRT.
“but a large percentage of subjects relapses to smoking within 6 to 12 months [210, 211].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [211]
A large percentage of subjects relapses to smoking within 6 to 12 months after NRT.
“but a large percentage of subjects relapses to smoking within 6 to 12 months [210, 211].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [210]
NRT roughly doubles quit rates compared to placebo.
“NRT roughly doubles quit rates compared to placebo”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [211]
Combining bupropion with NRT augments abstinence rates to 29%.
“which are further augmented to 29% when the drug is combined with NRT [210, 234, 235].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [210]
Cited by
Sorted by citations
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
- Authors
- HELGE, T. D., & DENELSKY, G. Y.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Cleveland Clinic Journal of Medicine
- Publisher
- Cleveland Clinic Journal of Medicine
- Published
- 2000-11-01
- Volume
- 67
- Issue
- 11
- Pages
- 818-823
- ISSN
- 0891-1150 (ISSN-L)
- 1939-2869
- OpenAlex
- W2320439883
- Cited by
- 7
- References
- 0
- Citations by year
- 2016: 1
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cleveland Clinic Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- smoking cessation, nicotine replacement therapy, bupropion, treatment efficacy, adverse effects
- MeSH terms
- Humans, Nicotine, Smoking Cessation, Bupropion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
